GWQ SERVICEPLUS AG has floated a tender for Conclusion of a Non-exclusive Discount Agreement According to Section 130a (8) Sgb V for the Active Ingredient Adalimumab. The project location is Germany and the tender is closing on 10 Nov 2022. The tender notice number is 027691-2021, while the TOT Ref Number is 49404458. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Conclusion of a Non-exclusive Discount Agreement According to Section 130a (8) Sgb V for the Active Ingredient Adalimumab

Deadline : 10 Nov 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 49404458

Document Ref. No. : 027691-2021

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : GWQ SERVICEPLUS AG
Address: acting for the statutory health insurance companies mentioned in detail under VI 2.)
Town: Düsseldorf
NUTS code: DE - GERMANY
Postal Code: 40474
Phone: +49 211758498-0
Fax: +49 211758498-48
Germany
Email :bieteranfrage@gwq-serviceplus.de
URL :http://www.gwq-serviceplus.de

Tender Details

Document Type: Corrigendum / Additional information (Please refer tender document)

Title: Conclusion of a non-exclusive discount agreement in accordance with Section 130a, Paragraph 8 of Book V of the Social Code (SGB V) for the active ingredient Adalimumab

Reference Number: 2021 / S 013-027691

Contract Type: Supplies

Description: Section 130a, Paragraph 8 of Book V of the Social Code enables the health insurances (KK) and pharmaceutical companies to conclude framework discount agreements on the drugs to be dispensed at the expense of the statutory KK. GWQ acts as a company for efficiency and quality at KK in accordance with Section 130a, Paragraph 8, Sentence 5 of the Social Security Code (SGBV) for its shareholder and customer accounts. With regard to the relevant legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures according to the regulations of the 4th part of the GWB takes place by GWQ ServicePlus AG. Until new drug discount agreements come into effect, GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies as part of the open-house procedure for preparations with the active ingredient adalimumab. The earliest contract start is January 1, 2021.



33600000 - Pharma ...

Documents

 Tender Notice